Impact of the coronavirus disease 2019 pandemic on the progression, prevalence, and incidence of myopia: A systematic review.

Autor:	Au Eong JTW; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Chen KS; International Eye Cataract Retina Centre, Mount Elizabeth Medical Centre and Farrer Park Medical Centre, Singapore., Teo BHK; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Lee SSY; Centre for Ophthalmology and Visual Science (Incorporating the Lions Eye Institute), University of Western Australia, Perth, Western Australia., Au Eong KG; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.; International Eye Cataract Retina Centre, Mount Elizabeth Medical Centre and Farrer Park Medical Centre, Singapore.; Department of Ophthalmology and Visual Sciences, Khoo Teck Puat Hospital, Singapore.
Jazyk:	angličtina
Zdroj:	Taiwan journal of ophthalmology [Taiwan J Ophthalmol] 2024 May 29; Vol. 14 (2), pp. 159-171. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).
DOI:	10.4103/tjo.TJO-D-24-00027
Abstrakt:	We systematically reviewed the literature on the effects of the coronavirus disease 2019 (COVID-19) pandemic on the progression, prevalence, and incidence of myopia. A comprehensive literature search was performed on PubMed, Cochrane Central Register of Controlled Trials, and Scopus databases. Studies included in the review assessed myopia progression, prevalence, and/or incidence as the primary outcome. Of 523 articles yielded in the initial search, 23 studies (6 cross-sectional and 17 cohort) were eligible for inclusion. Sixteen of these were conducted in China and one each in Hong Kong, Turkey, Spain, Israel, India, Korea, and Tibet. Quality appraisals were conducted with the Joanna Briggs Institute Critical Appraisal Checklists. Of the included studies, a large majority reported a greater myopic shift and increase in myopia prevalence during the COVID-19 pandemic compared to the pre-COVID-19 years. All three studies on myopia incidence showed increased incidence during the COVID-19 pandemic. Myopia progression accelerated during the COVID-19 pandemic, even in individuals using low-concentration atropine eye drops in two studies but not in those using orthokeratology treatment in one study. Overall, the studies found that the COVID-19 pandemic and its associated home confinement measures generally increased myopia progression, prevalence, and incidence, even in individuals using low-concentration atropine eye drops. Competing Interests: The authors declare that there are no conflicts of interest in this paper. (Copyright: © 2024 Taiwan J Ophthalmol.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu